INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Sagent Pharmaceuticals, Inc. ...
18 Julio 2016 - 11:55AM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All Persons or Entities who purchased Sagent
Pharmaceuticals, Inc. (“Sagent”) (NASDAQ: SGNT) stock prior to July 11, 2016.
You are hereby notified that Levi & Korsinsky, LLP
has commenced an investigation into the fairness of the
sale of Sagent to Nichi-Iko Pharmaceutical Co., Ltd. for $21.75
per share. To learn more about the action and your rights, go
to:
http://zlk.9nl.com/sagent-pharmaceuticals-sgnt
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972. There is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut, California, and Washington D.C. The
firm’s attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities lawsuits and have recovered
hundreds of millions of dollars for aggrieved shareholders. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160718006109/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
212-363-7171www.zlk.com
Sagent (NASDAQ:SGNT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Sagent (NASDAQ:SGNT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Sagent Pharmaceuticals, Inc. (NASDAQ): 0 recent articles
Más de Sagent Pharmaceuticals, Inc. (MM) Artículos de Noticias